P358 Risk of incident cancer in patients with inflammatory bowel disease starting anti-TNF therapy while having prior malignancy within past 5 years (GETAID survey)

✍ Scribed by Poullenot, F.; Seksik, P.; Beaugerie, L.; Amiot, A.; Nachury, M.; Abitbol, V.; Stefanescu, C.; Reenaers, C.; Fumery, M.; Pelletier, A.-L.; Nancey, S.; Peyrin-Biroulet, L.; Bourreille, A.; Hebuterne, X.; Brixi, H.; Savoye, G.; Lourenco, N.; Altwegg, R.; Bommelaer, G.; Cazelles-Boudier, C.; Racine, A.; Laharie, D.

• Book ID: 122285795
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 49 KB
• Volume: 8
• Category: Article
• ISSN: 1873-9946
• DOI: 10.1016/S1873-9946(14)60478-5